Skip to main content
Caplight Logo









Midland Pharmaceuticals

Midland Pharmaceuticals

Private
LondonHealthcare & Life Scienceshttps://midlandpharmaceuticals.com/

Last Round

Seed

May 21, 2024

Company Overview

Midland Pharmaceuticals is a clinical-stage pharmaceutical company developing novel therapeutics for neurodegenerative disorders, specifically focusing on spinal cord injury and ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryneurodegenerative disordersspinal cord injuryischemic strokeclinical trialsmatrix metalloproteinase inhibitorMMP inhibitorbiotech startuptherapeutic developmentsmall molecule therapeuticsdrug pipelinepharmaceutical researchneuroscience

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Midland Pharmaceuticals Comparables

Compare Midland Pharmaceuticals with similar companies based on industry and business-model similarity.

Midland Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioAxone BioSciences
79%
Astrocyte Pharmaceuticals Inc.
79%
Axonis Therapeutics
78%

Midland Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 21, 2024

Midland Pharmaceuticals Investors

Notable investors and investment history

Midland Pharmaceuticals investors
InvestorRounds
The University of SheffieldSeed
NLC Health VenturesSeed
University of BirminghamSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2024

    Led by NLC Health Ventures with participation from The University of Sheffield and University of Birmingham.

Midland Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Midland Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Midland Pharmaceuticals's valuation, stock price, and market status.

Is Midland Pharmaceuticals a public or private company?

Midland Pharmaceuticals is a private company.

What is the current stock price of Midland Pharmaceuticals?

Midland Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Midland Pharmaceuticals worth (valuation)?

Valuation information for Midland Pharmaceuticals is not publicly available.

Can I buy Midland Pharmaceuticals stock?

Midland Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Midland Pharmaceuticals's last funding round?

Midland Pharmaceuticals's most recent funding round was Seed on May 21, 2024.

Who are the main investors in Midland Pharmaceuticals?

Key investors in Midland Pharmaceuticals include NLC Health Ventures.

Will Midland Pharmaceuticals IPO soon?

No public IPO plans have been announced for Midland Pharmaceuticals.

How can I track Midland Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Midland Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Year Founded2024
Last FundingMay 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?